The Center for Neuroscience-based Mental Health Assessment and Prediction (NeuroMAP)
基于神经科学的心理健康评估和预测中心 (NeuroMAP)
基本信息
- 批准号:10711134
- 负责人:
- 金额:$ 251.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-15 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AnxietyAnxiety DisordersAreaArizonaAwardBehaviorBiologicalBrainCategoriesCellsComputer ModelsCountryDataDatabasesDiffusion Magnetic Resonance ImagingDiseaseDisease modelEmotionalEnvironmentExperimental DesignsExtramural ActivitiesFunctional Magnetic Resonance ImagingFundingFutureGoalsGrantImageIndividualInfrastructureInterventionLaboratoriesLeftLinkMedicalMental DepressionMental HealthMental disordersMentally Disabled PersonsMentorsMichiganMood DisordersMyelinNational Institute of Mental HealthNeurosciencesOklahomaPaperPhasePhysiologyPilot ProjectsPostdoctoral FellowPrefrontal CortexProcessPublishingRecurrenceRelapseReporterResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResearch TrainingResourcesRiskRobin birdServicesSeveritiesSouth CarolinaStandardizationSymptomsTalentsThinkingTimeTrainingUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesadaptive immunityanxious individualsavoidance behaviorbasecareercareer developmentcomorbiditydata managementdata repositorydiagnostic strategyexosomehealth assessmentimprovedinfrastructure developmentlanguage processingminority investigatorneuralneurofeedbackneuroimagingprogramsrecruitstatisticstooltranscranial direct current stimulationyoung adult
项目摘要
PROJECT SUMMARY: Overall
Mood and Anxiety Disorders are the most prevalent and disabling mental health conditions worldwide, yet
there are limited explanatory and predictive disease models available for these conditions. The theme of the
Neuroscience-based Mental Health Assessment and Prediction (NeuroMAP) CoBRE is based on the premise
that experimental designs that use transdiagnostic approaches (i.e., processes that cut across disease
categories) with multiple levels of analyses (symptoms & behavior, circuits & physiology, cells & molecules)
can identify disease modifying processes that can become targets of interventions. Phase I of NeuroMAP
recruited 8 RPLs and 8 PPIs. As of 6/2022, they applied for 99 extramural grants, received 8 federal grants,
and published 130 papers linked to the P20. Two underrepresented minority investigators using NeuroMAP
Core data received prestigious Maximizing Opportunities for Scientific and Academic Independent Careers
(MOSAIC) K99/R00 awards. Prior to the NeuroMAP CoBRE (funded 9/15/2017) the annual NIH funding for
LIBR was $662,104 (NIH Reporter accessed 6/17/2022), for 2021/22 the annual funding is $7,555,510
($5,368,214 without the CoBRE), which is a 11.4 (8.1)-fold increase. The goal for Phase II of the NeuroMAP
is to maintain and expand the infrastructure for RPLs. The Specific Aims of NeuroMAP are: (1) To expand
the critical mass of investigators that are focused on Neuroscience-based Mental Health Assessment and
Prediction approaches to mood and anxiety disorders. (2) To provide an operational infrastructure that
provides the tools necessary to conduct research projects, standardize assessments, and provide a data
repository for future pilot projects. (3) To provide a mentoring and career development infrastructure to junior
investigators to conduct studies focused on targetable, disease modifying processes in mood or anxiety
disorders. NeuroMAP will consists of: (a) an Administrative Core (Paulus); a Recruitment and Assessment
Core (Aupperle & Khalsa), a Circuit and Molecules Core (Rohan & Savitz), and a Data Management and
Statistics Core (Kuplicki & Thompson). There are three proposed projects: (1) Transcranial Direct Current
Stimulation: Threat Sensitivity target (Ironside) - External Mentor: Monique Ernst, NIMH; Internal Mentor:
Robin Aupperle, LIBR. (2) The effects of aversive interoceptive states on the computations and associated
neural basis of avoidance behavior (Smith) - External Mentor: Philip Corlett, Yale University; Internal Mentor:
Jennifer Stewart, LIBR. (3) Modulating repetitive negative thinking related brain networks in young adults
with depression (Tsuchiyagaito) - External Mentor: Kate Fitzgerald, University of Michigan; Internal Mentor:
Jonathan Savitz, LIBR. The goal of Phase II is to expand research in mood and anxiety disorders, build a
bigger base of funded investigators, and to attract more young talent to delineate the processes that
contribute to individuals developing, recovering from, and relapsing to mood and anxiety disorders.
项目概述:
项目成果
期刊论文数量(82)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Real-Time fMRI Functional Connectivity Neurofeedback Reducing Repetitive Negative Thinking in Depression: A Double-Blind, Randomized, Sham-Controlled Proof-of-Concept Trial.
- DOI:10.1159/000528377
- 发表时间:2023
- 期刊:
- 影响因子:22.8
- 作者:Tsuchiyagaito, Aki;Misaki, Masaya;Kirlic, Namik;Yu, Xiaoqian;Sanchez, Stella M.;Cochran, Gabe;Stewart, Jennifer L.;Smith, Ryan;Fitzgerald, Kate D.;Rohan, Michael L.;Paulus, Martin P.;Guinjoan, Salvador M.
- 通讯作者:Guinjoan, Salvador M.
Elevated decision uncertainty and reduced avoidance drives in depression, anxiety and substance use disorders during approach-avoidance conflict: a replication study.
- DOI:10.1503/jpn.220226
- 发表时间:2023-05
- 期刊:
- 影响因子:4.3
- 作者:Smith, Ryan;Lavalley, Claire A.;Taylor, Samuel;Stewart, Jennifer L.;Khalsa, Sahib S.;Berg, Hannah;Ironside, Maria;Paulus, Martin P.;Aupperle, Robin
- 通讯作者:Aupperle, Robin
Automated pipeline for EEG artifact reduction (APPEAR) recorded during fMRI.
- DOI:10.1088/1741-2552/ac1037
- 发表时间:2021-07-26
- 期刊:
- 影响因子:4
- 作者:Mayeli A;Al Zoubi O;Henry K;Wong CK;White EJ;Luo Q;Zotev V;Refai H;Bodurka J
- 通讯作者:Bodurka J
Reduced immunity to measles in adults with major depressive disorder.
- DOI:10.1017/s0033291718000661
- 发表时间:2019-01
- 期刊:
- 影响因子:6.9
- 作者:Ford BN;Yolken RH;Dickerson FB;Teague TK;Irwin MR;Paulus MP;Savitz J
- 通讯作者:Savitz J
The effects of FAAH inhibition on the neural basis of anxiety-related processing in healthy male subjects: a randomized clinical trial.
FAAH 抑制对健康男性受试者焦虑相关处理的神经基础的影响:一项随机临床试验。
- DOI:10.1038/s41386-020-00936-w
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Paulus,MartinP;Stein,MurrayB;Simmons,AlanN;Risbrough,VictoriaB;Halter,Robin;Chaplan,SandraR
- 通讯作者:Chaplan,SandraR
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARTIN P. PAULUS其他文献
MARTIN P. PAULUS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARTIN P. PAULUS', 18)}}的其他基金
NeuroMAP Phase II - Administrative Core
NeuroMAP 第二阶段 - 管理核心
- 批准号:
10711135 - 财政年份:2023
- 资助金额:
$ 251.23万 - 项目类别:
Target Engagement and Clinical Symptom Change with a FAAH Inhibitor for Posttraumatic Stress Disorder
FAAH 抑制剂治疗创伤后应激障碍的目标参与度和临床症状变化
- 批准号:
10356333 - 财政年份:2022
- 资助金额:
$ 251.23万 - 项目类别:
The Center for Neuroscience-based Mental Health Assessment and Prediction (NEUROMAP)
基于神经科学的心理健康评估和预测中心 (NEUROMAP)
- 批准号:
10002251 - 财政年份:2017
- 资助金额:
$ 251.23万 - 项目类别:
The Center for Neuroscience-based Mental Health Assessment and Prediction (NEUROMAP)
基于神经科学的心理健康评估和预测中心 (NEUROMAP)
- 批准号:
9210848 - 财政年份:2017
- 资助金额:
$ 251.23万 - 项目类别:
The Center for Neuroscience-based Mental Health Assessment and Prediction (NEUROMAP)
基于神经科学的心理健康评估和预测中心 (NEUROMAP)
- 批准号:
10246384 - 财政年份:2017
- 资助金额:
$ 251.23万 - 项目类别:
Latent Constructs: Negative-Positive Valence Domains in Anxiety and Depression
潜在结构:焦虑和抑郁中的负正价域
- 批准号:
8573425 - 财政年份:2013
- 资助金额:
$ 251.23万 - 项目类别:
相似海外基金
Using generative AI combined with immersive technology to treat anxiety disorders
利用生成式人工智能结合沉浸式技术治疗焦虑症
- 批准号:
10109165 - 财政年份:2024
- 资助金额:
$ 251.23万 - 项目类别:
Launchpad
Integration of stepped care for Perinatal Mood and Anxiety Disorders among Women Living with HIV in Kenya
肯尼亚艾滋病毒感染妇女围产期情绪和焦虑障碍的分级护理一体化
- 批准号:
10677075 - 财政年份:2023
- 资助金额:
$ 251.23万 - 项目类别:
Understanding the Effects of Adolescent Nicotine Exposure on Increased Risk for Mood and Anxiety Disorders: Bridging the Gap from Pre-Clinical to Clinical Investigations
了解青少年尼古丁暴露对情绪和焦虑障碍风险增加的影响:弥合临床前研究与临床研究之间的差距
- 批准号:
478121 - 财政年份:2023
- 资助金额:
$ 251.23万 - 项目类别:
Operating Grants
Addressing perinatal mood and anxiety disorders (PMADs) through a doula intervention
通过导乐干预解决围产期情绪和焦虑障碍 (PMAD)
- 批准号:
10861961 - 财政年份:2023
- 资助金额:
$ 251.23万 - 项目类别:
Evaluation of the effectiveness and implementation of online group cognitive behavioral therapy for perinatal women with anxiety disorders.
评估在线团体认知行为治疗对患有焦虑症的围产期妇女的有效性和实施情况。
- 批准号:
22KJ3164 - 财政年份:2023
- 资助金额:
$ 251.23万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Investigating the error-related negativity and the balance N1 in children with anxiety disorders
调查焦虑症儿童的错误相关消极性和平衡 N1
- 批准号:
10685283 - 财政年份:2022
- 资助金额:
$ 251.23万 - 项目类别:
RESONY: Digital therapeutic to manage anxiety disorders
RESONY:管理焦虑症的数字疗法
- 批准号:
10042996 - 财政年份:2022
- 资助金额:
$ 251.23万 - 项目类别:
Grant for R&D
Augmenting the Efficacy of Benzodiazepine Taper with Telehealth-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Patients Using Prescription Opioids
通过远程医疗提供的认知行为疗法来增强苯二氮卓类药物逐渐减少的疗效,以治疗使用处方阿片类药物的焦虑症患者
- 批准号:
10705005 - 财政年份:2022
- 资助金额:
$ 251.23万 - 项目类别:
Developing an adjunctive mobile application for co-morbid substance use and anxiety disorders: comprehensive user experience testing of the Unwinding Anxiety application
开发针对共病药物使用和焦虑症的辅助移动应用程序:Unwinding Anxiety 应用程序的综合用户体验测试
- 批准号:
10597521 - 财政年份:2022
- 资助金额:
$ 251.23万 - 项目类别:
Investigating the role of neuroinflammation in environmental exposure-induced anxiety disorders
研究神经炎症在环境暴露诱发的焦虑症中的作用
- 批准号:
10573948 - 财政年份:2022
- 资助金额:
$ 251.23万 - 项目类别:














{{item.name}}会员




